From Name:
From Email:
To Name:
To Email:

Optional Message:

Covidien: FDA approves Exalgo at higher dosage

from The Wall Street Journal

Covidien PLC said the Food and Drug Administration approved an extended-release 32-milligram version of the Exalgo pill for moderate-to-severe chronic pain requiring 24-hour treatment over an extended period. The latest approval expands options for physicians in treating opioid-tolerant patients. The FDA had approved eight milligram, 12 milligram and 16 milligram versions of the treatment in March 2010. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063